# ZoomInfo Technologies Inc.: financial statements, quarterly

GTM · Nasdaq · CIK 1794515 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gtm.md) · [Financials](/companies/gtm/financials.md) · [Filings](/companies/gtm/filings.md) · [Insiders](/companies/gtm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gtm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [314](/filings/0001794515-24-000185.md) | [316 d](/filings/0001794515-26-000012.md) | [310](/filings/0001794515-25-000100.md) | [292](/filings/0001794515-25-000167.md) | [304](/filings/0001794515-25-000184.md) | [309 d](/filings/0001794515-26-000012.md) | [306](/filings/0001794515-26-000038.md) | [307](/filings/0001794515-26-000056.md) | [318](/filings/0001794515-25-000184.md) | [319 d](/filings/0001794515-26-000012.md) | [310](/filings/0001794515-26-000038.md) | [310](/filings/0001794515-26-000056.md) |
| Gross profit | $m | [269](/filings/0001794515-24-000185.md) | [272 d](/filings/0001794515-26-000012.md) | [267](/filings/0001794515-25-000100.md) | [246](/filings/0001794515-25-000167.md) | [256](/filings/0001794515-25-000184.md) | [256 d](/filings/0001794515-26-000012.md) | [258](/filings/0001794515-26-000038.md) | [257](/filings/0001794515-26-000056.md) | [266](/filings/0001794515-25-000184.md) | [268 d](/filings/0001794515-26-000012.md) | [259](/filings/0001794515-26-000038.md) | [257](/filings/0001794515-26-000056.md) |
| Research and development | $m | [47.6](/filings/0001794515-24-000185.md) | [48.3 d](/filings/0001794515-26-000012.md) | [43.7](/filings/0001794515-25-000100.md) | [48.3](/filings/0001794515-25-000167.md) | [47.7](/filings/0001794515-25-000184.md) | [56.4 d](/filings/0001794515-26-000012.md) | [51.1](/filings/0001794515-26-000038.md) | [44.6](/filings/0001794515-26-000056.md) | [44.1](/filings/0001794515-25-000184.md) | [42.2 d](/filings/0001794515-26-000012.md) | [42.1](/filings/0001794515-26-000038.md) | [56.8](/filings/0001794515-26-000056.md) |
| Operating income | $m | [63.1](/filings/0001794515-24-000185.md) | [70.5 d](/filings/0001794515-26-000012.md) | [43.0](/filings/0001794515-25-000100.md) | [(20.0)](/filings/0001794515-25-000167.md) | [43.5](/filings/0001794515-25-000184.md) | [30.9 d](/filings/0001794515-26-000012.md) | [50.3](/filings/0001794515-26-000038.md) | [53.7](/filings/0001794515-26-000056.md) | [67.5](/filings/0001794515-25-000184.md) | [54.2 d](/filings/0001794515-26-000012.md) | [57.9](/filings/0001794515-26-000038.md) | [(622)](/filings/0001794515-26-000056.md) |
| Interest expense | $m | [11.9](/filings/0001794515-23-000169.md) | [11.4 d](/filings/0001794515-24-000016.md) | [10.1](/filings/0001794515-24-000074.md) | [9.8](/filings/0001794515-25-000167.md) | [9.6](/filings/0001794515-25-000184.md) | [9.8 d](/filings/0001794515-26-000012.md) | [9.8](/filings/0001794515-26-000038.md) | [10.7](/filings/0001794515-26-000056.md) | [11.5](/filings/0001794515-25-000184.md) | [10.6 d](/filings/0001794515-26-000012.md) | [13.5](/filings/0001794515-26-000038.md) | [14.7](/filings/0001794515-26-000056.md) |
| Income tax | $m | [29.0](/filings/0001794515-24-000185.md) | [212 d](/filings/0001794515-26-000012.md) | [14.4](/filings/0001794515-25-000100.md) | [(0.2)](/filings/0001794515-25-000167.md) | [11.1](/filings/0001794515-25-000184.md) | [(23.1) d](/filings/0001794515-26-000012.md) | [12.8](/filings/0001794515-26-000038.md) | [33.0](/filings/0001794515-26-000056.md) | [17.7](/filings/0001794515-25-000184.md) | [6.6 d](/filings/0001794515-26-000012.md) | [15.0](/filings/0001794515-26-000038.md) | [25.2](/filings/0001794515-26-000056.md) |
| Net income | $m | [30.2](/filings/0001794515-24-000185.md) | [(5.5) d](/filings/0001794515-26-000012.md) | [15.1](/filings/0001794515-25-000184.md) | [(24.4)](/filings/0001794515-25-000184.md) | [23.8](/filings/0001794515-25-000184.md) | [14.6 d](/filings/0001794515-26-000012.md) | [26.8](/filings/0001794515-26-000056.md) | [24.0](/filings/0001794515-26-000056.md) | [38.7](/filings/0001794515-25-000184.md) | [34.7 d](/filings/0001794515-26-000012.md) | [29.3](/filings/0001794515-26-000056.md) | [(644)](/filings/0001794515-26-000056.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001794515-24-000185.md) | not reported | [0.04](/filings/0001794515-25-000100.md) | [(0.07)](/filings/0001794515-25-000167.md) | [0.07](/filings/0001794515-25-000184.md) | not reported | [0.08](/filings/0001794515-26-000038.md) | [0.07](/filings/0001794515-26-000056.md) | [0.12](/filings/0001794515-25-000184.md) | not reported | [0.10](/filings/0001794515-26-000038.md) | [(2.19)](/filings/0001794515-26-000056.md) |
| Basic EPS | $ per share | [0.08](/filings/0001794515-24-000185.md) | not reported | [0.04](/filings/0001794515-25-000100.md) | [(0.07)](/filings/0001794515-25-000167.md) | [0.07](/filings/0001794515-25-000184.md) | not reported | [0.08](/filings/0001794515-26-000038.md) | [0.07](/filings/0001794515-26-000056.md) | [0.12](/filings/0001794515-25-000184.md) | not reported | [0.10](/filings/0001794515-26-000038.md) | [(2.19)](/filings/0001794515-26-000056.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [443](/filings/0001794515-24-000185.md) | [447](/filings/0001794515-26-000012.md) | [406](/filings/0001794515-25-000100.md) | [386](/filings/0001794515-25-000167.md) | [148](/filings/0001794515-25-000184.md) | [140](/filings/0001794515-26-000012.md) | [139](/filings/0001794515-26-000038.md) | [171](/filings/0001794515-26-000056.md) | [125](/filings/0001794515-25-000184.md) | [176](/filings/0001794515-26-000056.md) | [171](/filings/0001794515-26-000038.md) | [148](/filings/0001794515-26-000056.md) |
| Current assets | $m | [855](/filings/0001794515-23-000169.md) | [864](/filings/0001794515-25-000045.md) | [740](/filings/0001794515-24-000074.md) | [660](/filings/0001794515-24-000137.md) | [391](/filings/0001794515-24-000185.md) | [451](/filings/0001794515-26-000012.md) | [410](/filings/0001794515-25-000100.md) | [439](/filings/0001794515-25-000167.md) | [372](/filings/0001794515-25-000184.md) | [454](/filings/0001794515-26-000056.md) | [410](/filings/0001794515-26-000038.md) | [398](/filings/0001794515-26-000056.md) |
| Total assets | $m | [7,071](/filings/0001794515-23-000169.md) | [6,868](/filings/0001794515-25-000045.md) | [6,754](/filings/0001794515-24-000074.md) | [6,684](/filings/0001794515-24-000137.md) | [6,395](/filings/0001794515-24-000185.md) | [6,468](/filings/0001794515-26-000012.md) | [6,406](/filings/0001794515-25-000100.md) | [6,453](/filings/0001794515-25-000167.md) | [6,370](/filings/0001794515-25-000184.md) | [6,440](/filings/0001794515-26-000056.md) | [6,370](/filings/0001794515-26-000038.md) | [5,679](/filings/0001794515-26-000056.md) |
| Current liabilities | $m | [573](/filings/0001794515-23-000169.md) | [638](/filings/0001794515-25-000045.md) | [664](/filings/0001794515-24-000074.md) | [681](/filings/0001794515-24-000137.md) | [624](/filings/0001794515-24-000185.md) | [652](/filings/0001794515-26-000012.md) | [624](/filings/0001794515-25-000100.md) | [619](/filings/0001794515-25-000167.md) | [557](/filings/0001794515-25-000184.md) | [633](/filings/0001794515-26-000056.md) | [599](/filings/0001794515-26-000038.md) | [611](/filings/0001794515-26-000056.md) |
| Total liabilities | $m | [4,821](/filings/0001794515-23-000169.md) | [4,749](/filings/0001794515-25-000045.md) | [4,748](/filings/0001794515-24-000074.md) | [4,821](/filings/0001794515-24-000137.md) | [4,727](/filings/0001794515-24-000185.md) | [4,774](/filings/0001794515-26-000012.md) | [4,760](/filings/0001794515-25-000100.md) | [4,901](/filings/0001794515-25-000167.md) | [4,839](/filings/0001794515-25-000184.md) | [4,931](/filings/0001794515-26-000056.md) | [4,896](/filings/0001794515-26-000038.md) | [4,850](/filings/0001794515-26-000056.md) |
| Long-term debt | $m | [1,227](/filings/0001794515-23-000169.md) | [1,226](/filings/0001794515-25-000045.md) | [1,225](/filings/0001794515-24-000074.md) | [1,224](/filings/0001794515-24-000137.md) | [1,223](/filings/0001794515-24-000185.md) | [1,222](/filings/0001794515-26-000012.md) | [1,221](/filings/0001794515-25-000100.md) | [1,320](/filings/0001794515-25-000167.md) | [1,319](/filings/0001794515-25-000184.md) | [1,318](/filings/0001794515-26-000056.md) | [1,317](/filings/0001794515-26-000038.md) | [1,258](/filings/0001794515-26-000056.md) |
| Current portion of debt | $m | [6.0](/filings/0001794515-23-000169.md) | [6.0](/filings/0001794515-25-000045.md) | [6.0](/filings/0001794515-24-000074.md) | [5.9](/filings/0001794515-24-000137.md) | [5.9](/filings/0001794515-24-000185.md) | [5.9](/filings/0001794515-26-000012.md) | [5.9](/filings/0001794515-25-000100.md) | [5.9](/filings/0001794515-25-000167.md) | [5.9](/filings/0001794515-25-000184.md) | [5.9](/filings/0001794515-26-000056.md) | [5.9](/filings/0001794515-26-000038.md) | [5.9](/filings/0001794515-26-000056.md) |
| Shareholders' equity | $m | [2,250](/filings/0001794515-24-000185.md) | [2,119](/filings/0001794515-26-000012.md) | [2,006](/filings/0001794515-25-000184.md) | [1,863](/filings/0001794515-25-000184.md) | [1,668](/filings/0001794515-25-000184.md) | [1,694](/filings/0001794515-26-000056.md) | [1,646](/filings/0001794515-26-000056.md) | [1,552](/filings/0001794515-26-000056.md) | [1,531](/filings/0001794515-25-000184.md) | [1,509](/filings/0001794515-26-000056.md) | [1,474](/filings/0001794515-26-000056.md) | [829](/filings/0001794515-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [80.9 d](/filings/0001794515-24-000185.md) | [129 d](/filings/0001794515-26-000012.md) | [116](/filings/0001794515-25-000100.md) | [126 d](/filings/0001794515-25-000167.md) | [18.2 d](/filings/0001794515-25-000184.md) | [109 d](/filings/0001794515-26-000012.md) | [119](/filings/0001794515-26-000038.md) | [109 d](/filings/0001794515-26-000056.md) | [93.8 d](/filings/0001794515-25-000184.md) | [144 d](/filings/0001794515-26-000012.md) | [115](/filings/0001794515-26-000038.md) | [87.3 d](/filings/0001794515-26-000056.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001794515-24-000185.md) | [8.9 d](/filings/0001794515-26-000012.md) | [12.8](/filings/0001794515-25-000100.md) | [11.1 d](/filings/0001794515-25-000167.md) | [17.6 d](/filings/0001794515-25-000184.md) | [23.4 d](/filings/0001794515-26-000012.md) | [14.8](/filings/0001794515-26-000038.md) | [22.0 d](/filings/0001794515-26-000056.md) | [22.9 d](/filings/0001794515-25-000184.md) | [16.4 d](/filings/0001794515-26-000012.md) | [24.1](/filings/0001794515-26-000038.md) | [17.6 d](/filings/0001794515-26-000056.md) |
| Share repurchases | $m | [160 d](/filings/0001794515-24-000185.md) | [153 d](/filings/0001794515-26-000012.md) | [151](/filings/0001794515-25-000100.md) | [148 d](/filings/0001794515-25-000167.md) | [243 d](/filings/0001794515-25-000184.md) | [23.0 d](/filings/0001794515-26-000012.md) | [95.0](/filings/0001794515-26-000038.md) | [149 d](/filings/0001794515-26-000056.md) | [87.0 d](/filings/0001794515-25-000184.md) | [79.8 d](/filings/0001794515-26-000012.md) | [90.9](/filings/0001794515-26-000038.md) | [31.5 d](/filings/0001794515-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [371](/filings/0001794515-25-000167.md) | [355](/filings/0001794515-25-000184.md) | [341](/filings/0001794515-26-000038.md) | [327](/filings/0001794515-26-000056.md) | [317](/filings/0001794515-25-000184.md) | [302](/filings/0001794515-26-000038.md) | [295](/filings/0001794515-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 291,110,046 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001794515-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.